Literature DB >> 10523816

Radiation hybrid mapping of genes in the lithium-sensitive wnt signaling pathway.

A R Rhoads1, J D Karkera, S D Detera-Wadleigh.   

Abstract

Lithium, an effective drug in the treatment of bipolar disorder, has been proposed to disrupt the Wnt signaling pathway. To facilitate analysis of the possible involvement of elements of the Wnt pathway in human bipolar disorder, a high resolution radiation hybrid mapping (RHM) of these genes was performed. A fine physical location has been obtained for Wnt 7A, frizzled 3, 4 and 5, dishevelled 1, 2 and 3, GSK3beta, axin, alpha-catenin, the Armadillo repeat-containing genes (delta-catenin and ARVCF), and a frizzled-like protein (frpHE) using the Stanford Human Genome Center (SHGC) G3 panel. Most of these genes were previously mapped by fluorescence in situ hybridization (FISH). Frizzled 4, axin and frpHE did not have a previous chromosomal assignment and were linked by RHM to chromosome markers, SHGC-35131 at 11q22.1, NIB1488 at 16p13.3 and D7S2919 at 7p15.2, respectively. Interestingly, some of these genes were found to map within potential regions underlying susceptibility to bipolar disorder and schizophrenia as well as disorders of neurodevelopmental origin. This alternative approach of establishing the precise location of selected genetic components of a candidate pathway and determining if they map within previously defined susceptibility loci should help to identify plausible candidate genes that warrant further analysis through association and mutational scanning.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523816     DOI: 10.1038/sj.mp.4000538

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  2 in total

Review 1.  Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.

Authors:  Xiaohua Li; Gautam N Bijur; Richard S Jope
Journal:  Bipolar Disord       Date:  2002-04       Impact factor: 6.744

Review 2.  Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases.

Authors:  Qun Lu; Byron J Aguilar; Mingchuan Li; Yongguang Jiang; Yan-Hua Chen
Journal:  Hum Genet       Date:  2016-07-05       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.